Nykode Therapeutics AS (NYKD.OL)
NOK 2.59
(15.42%)
NOK 2.59
(15.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.59 Billion USD | 19.49% |
| 2022 | -1.97 Billion USD | -7.34% |
| 2021 | -1.84 Billion USD | -17.3% |
| 2020 | -1.57 Billion USD | -1675.28% |
| 2019 | -88.53 Million NOK | -172.9% |
| 2018 | -32.44 Million NOK | 19.45% |
| 2017 | -40.27 Million NOK | -105.14% |
| 2016 | -19.63 Million NOK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -131.74 Million USD | 7.33% |
| 2024 Q1 | -1.54 Billion USD | 9.0% |
| 2023 FY | -1.59 Billion USD | 19.49% |
| 2023 Q4 | -1.59 Billion USD | 2.36% |
| 2023 Q3 | -1.63 Billion USD | 9.08% |
| 2023 Q2 | -1.79 Billion USD | 5.15% |
| 2023 Q1 | -1.89 Billion USD | 4.38% |
| 2022 Q3 | -2.25 Billion NOK | -10.07% |
| 2022 Q4 | -1.97 Billion USD | 12.21% |
| 2022 Q2 | -2.04 Billion NOK | -7.1% |
| 2022 Q1 | -1.91 Billion NOK | -3.73% |
| 2021 Q4 | -1.84 Billion NOK | -22.37% |
| 2021 Q3 | -1.5 Billion NOK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Arctic Bioscience AS | -77.55 Million NOK | -1954.309% |
| Aqua Bio Technology ASA | -5.82 Million NOK | -27233.121% |
| ArcticZymes Technologies ASA | -237.27 Million NOK | -571.457% |
| BerGenBio ASA | -155.55 Million NOK | -924.221% |
| Hofseth BioCare ASA | 112.89 Million NOK | 1511.16% |
| PCI Biotech Holding ASA | -40.86 Million NOK | -3798.751% |
| Thor Medical ASA | -41.28 Million NOK | -3759.087% |
| Ultimovacs ASA | -262.84 Million NOK | -506.129% |